{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T07:47:17Z","timestamp":1791791237655,"version":"4.3.4"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014835","name":"Istituto Nazionale Tumori IRCCS Fondazione Pascale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.critrevonc.2026.105608","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:28:23Z","timestamp":1789914503000},"page":"105608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Current management and investigational therapeutic strategies in penile squamous cell carcinoma: A narrative review"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4124-2837","authenticated-orcid":false,"given":"Lorenzo","family":"Lobianco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Calvanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"D\u2019Alessio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Passaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Passarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jole","family":"Ventriglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Chiara","family":"Cecere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Tambaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena Di","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Contieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Aveta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pacifico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Lamia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florinda","family":"Feroce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Sepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Perasole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Troiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Pignata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105608_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/bju.15309","article-title":"Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis","volume":"128","author":"Ager","year":"2021","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2026.105608_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1634\/theoncologist.2015-0241","article-title":"Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations","volume":"21","author":"Ali","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2026.105608_bib3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.eururo.2012.02.052","article-title":"Treatment of Carcinoma In Situ of the Glans Penis with Topical Chemotherapy Agents","volume":"62","author":"Alnajjar","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ccell.2025.03.023","article-title":"Neoadjuvant toripalimab plus nimotuzumab combined with taxol-based chemotherapy in locally advanced penile squamous cell carcinoma","volume":"43","author":"An","year":"2025","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105608_bib5","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1200\/JCO.23.02233","article-title":"Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced\/Metastatic Genitourinary Tumors","volume":"42","author":"Apolo","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s11255-025-04911-6","article-title":"Penile cancer and lymph node management: a call for standardization","author":"Aveta","year":"2025","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.2025.43.5_suppl.1","article-title":"EPIC-A: Phase II trial of cemiplimab plus standard of care chemotherapy followed by maintenance cemiplimab in locally advanced or metastatic penile carcinoma","volume":"43","author":"Bahl","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.euo.2020.10.011","article-title":"Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma","volume":"4","author":"Bandini","year":"2021","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2010.09.010","article-title":"Glanuloplasty With Urethral Flap After Partial Penectomy","author":"Belinky","year":"2011","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib10","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s43018-025-01004-2","article-title":"Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and\/or metastatic squamous cell carcinomas: a phase 2 basket trial","volume":"6","author":"Borcoman","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105608_bib11","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/1878-0261.13519","article-title":"Transcriptomic profiling of peripheral blood cells in HPV-associated carcinoma patients receiving combined valproic acid and avelumab","volume":"18","author":"Bozorgmehr","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.urology.2016.01.003","article-title":"Role of Penile Doppler US in the Preoperative Assessment of Penile Squamous Cell Carcinoma Patients: Results From a Large Prospective Multicenter European Study","volume":"90","author":"Bozzini","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2026.105608_bib13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.eururo.2023.02.027","article-title":"European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update","volume":"83","author":"Brouwer","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.urology.2013.08.074","article-title":"Epidermal Growth Factor Receptor-targeted Therapy in Squamous Cell Carcinoma of the Penis: A Report of 3 Cases","volume":"83","author":"Brown","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2026.105608_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fphar.2016.00487","article-title":"Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study","volume":"7","author":"Buonerba","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijrobp.2013.08.013","article-title":"Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis","volume":"88","author":"Burt","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105608_bib17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/bju.12450","article-title":"Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis","volume":"113","author":"Carthon","year":"2014","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2026.105608_bib18","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-20-4004","article-title":"Whole-exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma","volume":"27","author":"Chahoud","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105608_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MOU.0000000000000640","article-title":"Genetics and penile cancer: recent developments and implications","volume":"29","author":"Chahoud","year":"2019","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1200\/JCO.2025.43.5_suppl.9","article-title":"EPIC-B: Phase II trial of cemiplimab as first-line treatment in advanced penile carcinoma","volume":"43","author":"Challapalli","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib21","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1177\/0300060519863546","article-title":"A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and\/or metastatic carcinoma of the penis","volume":"47","author":"Challapalli","year":"2019","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.critrevonc.2026.105608_bib22","doi-asserted-by":"crossref","first-page":"TPS5093","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS5093","article-title":"Camrelizumab combined with TIP (paclitaxel+cisplatin+ifosfamide) as neoadjuvant treatment of locally advanced penile cancer before lymphadenectomy: An exploratory, phase \u2161 study","volume":"40","author":"Chen","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib23","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/cancers12071796","article-title":"Immunophenotypes Based on the Tumor Immune Microenvironment Allow for Unsupervised Penile Cancer Patient Stratification","volume":"12","author":"Chu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105608_bib24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","article-title":"Penile Cancer","volume":"11","author":"Clark","year":"2013","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.critrevonc.2026.105608_bib25","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.21037\/tau.2020.04.02","article-title":"Technical management of inguinal lymph-nodes in penile cancer: open versus minimal invasive","volume":"10","author":"Correa","year":"2021","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib26","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jamaoncol.2025.3266","article-title":"Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With Advanced Penile Cancer: The Nonrandomized HERCULES (LACOG 0218) Clinical Trial","volume":"11","author":"Cotait Maluf","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib27","first-page":"184","article-title":"Organ preserving radiation strategies for penile cancer","volume":"40","author":"Crook","year":"2022","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"10.1016\/j.critrevonc.2026.105608_bib28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.euo.2018.07.010","article-title":"PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes","volume":"2","author":"Davidsson","year":"2019","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/bju.15678","article-title":"Clinicopathological predictors of finding additional inguinal lymph node metastases in penile cancer patients after positive dynamic sentinel node biopsy: a European multicentre evaluation","volume":"130","author":"de Vries","year":"2022","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2026.105608_bib30","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1200\/JCO.22.02894","article-title":"Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial","volume":"41","author":"de Vries","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib31","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eururo.2020.09.007","article-title":"Hybrid Indocyanine Green\u201399mTc-nanocolloid for Single-photon Emission Computed Tomography and Combined Radio- and Fluorescence-guided Sentinel Node Biopsy in Penile Cancer: Results of 740 Inguinal Basins Assessed at a Single Institution","volume":"78","author":"Dell\u2019Oglio","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib32","doi-asserted-by":"crossref","first-page":"LBA5012","DOI":"10.1200\/JCO.2025.43.17_suppl.LBA5012","article-title":"An open label randomized non-inferiority trial comparing adjuvant platinum plus paclitaxel to platinum plus 5-FU after curative resection in high-risk penile carcinoma","volume":"43","author":"Dhanawat","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib33","doi-asserted-by":"crossref","first-page":"E661","DOI":"10.1111\/j.1464-410X.2012.11453.x","article-title":"Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis","volume":"110","author":"Di Lorenzo","year":"2012","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2026.105608_bib34","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.eururo.2011.08.028","article-title":"Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study","volume":"60","author":"Di Lorenzo","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2013.07.088","article-title":"Contemporary management of regional nodes in penile cancer-improvement of survival?","volume":"191","author":"Djajadiningrat","year":"2014","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib36","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.juro.2014.12.019","article-title":"Prophylactic pelvic lymph node dissection in patients with penile cancer","volume":"193","author":"Djajadiningrat","year":"2015","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib37","doi-asserted-by":"crossref","first-page":"785","DOI":"10.21037\/tau.2017.05.19","article-title":"Updates on the epidemiology and risk factors for penile cancer","volume":"6","author":"Douglawi","year":"2017","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib38","article-title":"Feasibility and effectiveness of second-line chemotherapy with mitomycin C in patients with advanced penile cancer","volume":"3","author":"Draeger","year":"2023","journal-title":"Front. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib39","article-title":"HPV Vaccination: Does It Have a Role in Preventing Penile Cancer and Other Preneoplastic Lesions?","volume":"38","author":"Elst","year":"2022","journal-title":"Seminars Oncology Nursing Penile Cancer Optimizing care patients their families"},{"key":"10.1016\/j.critrevonc.2026.105608_bib40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijrobp.2017.02.090","article-title":"Brachytherapy for Conservative Treatment of Invasive Penile Carcinoma: Prognostic Factors and Long-Term Analysis of Outcome","volume":"99","author":"Escande","year":"2017","journal-title":"Int. J. Radiat. Oncol. *Biol. *Phys."},{"key":"10.1016\/j.critrevonc.2026.105608_bib41","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.eururo.2020.07.025","article-title":"Total Phallic Reconstruction in the Genetic Male","volume":"79","author":"Falcone","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib42","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00432-022-04012-2","article-title":"Lymphovascular and perineural invasion are risk factors for inguinal lymph node metastases in men with T1G2 penile cancer","volume":"148","author":"Fankhauser","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"587\u2013591","key":"10.1016\/j.critrevonc.2026.105608_bib43","first-page":"591","article-title":"Epidemiologic study on penile cancer in Brazil","volume":"34","author":"Favorito","year":"2008","journal-title":"Int. Braz. J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib44","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-15-3134","article-title":"CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma","volume":"76","author":"Feber","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105608_bib45","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/jamaoncol.2024.6998","article-title":"Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical Trial","volume":"11","author":"Floudas","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib46","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.juro.2011.03.117","article-title":"Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals","volume":"186","author":"Franks","year":"2011","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib47","doi-asserted-by":"crossref","DOI":"10.2196\/34874","article-title":"Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study","volume":"8","author":"Fu","year":"2022","journal-title":"JMIR Public. Health Surveill."},{"key":"10.1016\/j.critrevonc.2026.105608_bib48","first-page":"221","article-title":"Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma","volume":"17","author":"Gambachidze","year":"2018","journal-title":"Brachytherapy Treat. Deliv. Verif. Brachytherapy Prospects Technol. Innov."},{"key":"10.1016\/j.critrevonc.2026.105608_bib49","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.euo.2024.04.021","article-title":"Retifanlimab in Advanced Penile Squamous Cell Carcinoma: The Phase 2 ORPHEUS Study","volume":"8","author":"Garc\u00eda Del Muro","year":"2025","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib50","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1158\/1078-0432.CCR-21-3726","article-title":"Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy","volume":"28","author":"Girardi","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105608_bib51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105608_bib52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1473-3099(21)00327-3","article-title":"Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial","volume":"22","author":"Goldstone","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.critrevonc.2026.105608_bib53","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1464-410X.2009.08894.x","article-title":"Repeat dynamic sentinel node biopsy in locally recurrent penile carcinoma","volume":"105","author":"Graafland","year":"2010","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2026.105608_bib54","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0022-5347(05)68815-5","article-title":"Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study","volume":"161","author":"Haas","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib55","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s10637-021-01100-x","article-title":"Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial","volume":"39","author":"Hahn","year":"2021","journal-title":"Invest. New. Drugs"},{"key":"10.1016\/j.critrevonc.2026.105608_bib56","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1464-410X.2006.06496.x","article-title":"Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma","volume":"98","author":"Hakenberg","year":"2006","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2026.105608_bib57","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.brachy.2015.03.008","article-title":"The role of brachytherapy in organ preservation for penile cancer: A meta-analysis and review of the literature","volume":"14","author":"Hasan","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.critrevonc.2026.105608_bib58","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1080\/14796694.2025.2577632","article-title":"Phase 2 study of dostarlimab plus niraparib in stage III-IV recurrent or refractory Penile squamous cell carcinoma","volume":"21","author":"Hatoum","year":"2025","journal-title":"Future Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib59","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.e15001","article-title":"Preliminary safety and pharmacodynamic (PD) activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in a phase I dose escalation study of patients with selected advanced solid tumors","volume":"38","author":"Hickingbottom","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib60","author":"Hinrichs","year":"2026","journal-title":"A Feasibility Study E7 TCR-T Cell Induction Therapy Locoregionally Advanced HPV-Associated Cancers (Clinical trial registration No. NCT05639972)"},{"key":"10.1016\/j.critrevonc.2026.105608_bib61","author":"Hinrichs","year":"2026","journal-title":"A Phase II Trial T Cell Receptor Gene Therapy Targeting Human Papillomavirus ( HPV) 16 E7 HPV-Associated Cancers (Clinical trial registration No. NCT05686226)"},{"key":"10.1016\/j.critrevonc.2026.105608_bib62","author":"Hookipa Biotech GmbH","year":"2025","journal-title":"A Phase I\/II Study Thera \u00ae Vector(S. ) Express Human. Papillomavirus 16 Posit. (HPV 16+) Specif. Antigens Patients HPV 16+ Confirmed Cancers (Clin. Trial Regist. No. NCT04180215)"},{"key":"10.1016\/j.critrevonc.2026.105608_bib63","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5575730","article-title":"VEILND (Video Endoscopic Inguinal Lymph Node Dissection) with Florescence Indocyanine Green (ICG): A Novel Technique to Identify the Sentinel Lymph Node in Men with \u2265pT1G2 and cN0 Penile Cancer","volume":"2021","author":"Hora","year":"2021","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.critrevonc.2026.105608_bib64","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5347(05)67982-7","article-title":"Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure","volume":"163","author":"Horenblas","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib65","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0022-5347(17)35221-7","article-title":"Squamous Cell Carcinoma of the Penis. IV. Prognostic Factors of Survival: Analysis of Tumor, Nodes and Metastasis Classification System","volume":"151","author":"Horenblas","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00345-008-0288-6","article-title":"Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer","volume":"27","author":"Hughes","year":"2009","journal-title":"World J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib67","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/1097-0142(19900201)65:3<433::AID-CNCR2820650310>3.0.CO;2-G","article-title":"Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas","volume":"65","author":"Hussein","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105608_bib68","author":"Institut f\u00fcr Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","year":"2025","journal-title":"DEPECA-1 - DEfeating PEnile Cancer 1 - A Phase II Study Evaluate a First-line Systemic Therapy Enfortumab Vedotin Avelumab Advanced Metastatic Penile Carcinoma (Clinical trial registration No. NCT07110038)"},{"key":"10.1016\/j.critrevonc.2026.105608_bib69","doi-asserted-by":"crossref","first-page":"641.e9","DOI":"10.1016\/j.urolonc.2020.03.026","article-title":"Adjuvant radiation compares favorably to chemotherapy in patients with carcinoma penis and nodal positivity restricted to groin","volume":"38","author":"Jaipuria","year":"2020","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib70","unstructured":"Ji, Wenli, 2021. A Single-arm, Open, Multicenter, Phase II Clinical Study of the Efficacy and Safety of Human Anti-PD-L1 Monoclonal Antibody Injection (LDP) in the Treatment of Urinary and Male Genital Tumors (Clinical trial registration No. NCT04718584). clinicaltrials.gov."},{"key":"10.1016\/j.critrevonc.2026.105608_bib71","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.urology.2003.12.026","article-title":"Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer","volume":"63","author":"Joerger","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2026.105608_bib72","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.euf.2018.10.007","article-title":"Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes","volume":"5","author":"Johnstone","year":"2019","journal-title":"Eur. Urol. Focus."},{"key":"10.1016\/j.critrevonc.2026.105608_bib73","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41585-022-00617-x","article-title":"Immune-based therapies in penile cancer","volume":"19","author":"Joshi","year":"2022","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib74","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/bju.16692","article-title":"Efficacy of human papillomavirus vaccines in the prevention of male genital diseases: a systematic review","volume":"135","author":"Kardoust Parizi","year":"2025","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2026.105608_bib75","doi-asserted-by":"crossref","first-page":"722","DOI":"10.5858\/arpa.2021-0592-RA","article-title":"Molecular Pathogenesis of Penile Squamous Cell Carcinoma: Current Understanding and Potential Treatment Implications","volume":"147","author":"Keller","year":"2022","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.critrevonc.2026.105608_bib76","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/j.prro.2022.11.001","article-title":"Optimizing Target Volume for Adjuvant Radiation Therapy in Penile Cancer","volume":"13","author":"Khurud","year":"2023","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib77","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clon.2021.10.005","article-title":"Impact of Adjuvant Treatment in pN3 Penile Cancer","volume":"34","author":"Khurud","year":"2022","journal-title":"Clin. Oncol. (R. Coll. Radiol. )"},{"issue":"Spec 1","key":"10.1016\/j.critrevonc.2026.105608_bib78","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1259\/bjr\/63301362","article-title":"MRI of the penis","volume":"85","author":"Kirkham","year":"2012","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib79","doi-asserted-by":"crossref","first-page":"TPS4627","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS4627","volume":"42","author":"Kydd","year":"2024","journal-title":"JCO"},{"key":"10.1016\/j.critrevonc.2026.105608_bib80","doi-asserted-by":"crossref","first-page":"66352","DOI":"10.18632\/oncotarget.18558","article-title":"Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105608_bib81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00345-020-03179-y","article-title":"Radiotherapy plus chemotherapy versus chemotherapy alone in penile cancer patients with extracapsular nodal extension after inguinal lymph node surgery: a multi-institutional study","volume":"39","author":"Li","year":"2021","journal-title":"World J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib82","author":"Liu","year":"2025","journal-title":"MRG003 HX008 First-Line Treatment EGFR-Positive Locally Advanced Metastatic Penile Squamous Cell Carcinoma A Prospective Single-Arm Phase I Clinical Trial (Clinical trial registration No. NCT07054307)"},{"key":"10.1016\/j.critrevonc.2026.105608_bib83","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00345-013-1024-4","article-title":"The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection","volume":"31","author":"Liu","year":"2013","journal-title":"World J. Urol."},{"issue":"947\u2013952","key":"10.1016\/j.critrevonc.2026.105608_bib84","first-page":"952","article-title":"Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival","volume":"177","author":"Lont","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib85","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.juro.2013.10.140","article-title":"The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience","volume":"191","author":"Lughezzani","year":"2014","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib86","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1038\/s41598-017-06659-1","article-title":"Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma","volume":"7","author":"Marchi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105608_bib87","first-page":"89","article-title":"High-dose rate brachytherapy in localized penile cancer: 5-Year clinical outcome analysis","volume":"27","author":"Martz","year":"2021","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib88","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","article-title":"HPV-associated head and neck cancer: a virus-related cancer epidemic","volume":"11","author":"Marur","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib89","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","article-title":"Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy","volume":"75","author":"McDaniel","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105608_bib90","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/cncr.33328","article-title":"Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies","volume":"127","author":"McGregor","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105608_bib91","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs\u2014Part A: Renal, Penile, and Testicular Tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib92","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/oncolo\/oyad085","article-title":"Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent\/Metastatic Human Papillomavirus-Associated Cancers","volume":"28","author":"Morris","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2026.105608_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103481","article-title":"Penile cancer: ESMO\u2013EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"9","author":"Muneer","year":"2024","journal-title":"ESMO Open."},{"key":"10.1016\/j.critrevonc.2026.105608_bib94","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2024.7078","article-title":"The Prognostic Role of HPV or p16INK4a Status in Penile Squamous Cell Carcinoma: A Meta-Analysis","volume":"23","author":"Mustasam","year":"2025","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"10.1016\/j.critrevonc.2026.105608_bib95","author":"National Cancer Institute (NCI)","year":"2026","journal-title":"DART Dual Anti-CTLA-4 Anti-PD-1 Block Rare Tumors (Clin. Trial Regist. No. NCT02834013)"},{"key":"10.1016\/j.critrevonc.2026.105608_bib96","doi-asserted-by":"crossref","first-page":"531.e7","DOI":"10.1016\/j.urolonc.2019.04.003","article-title":"Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: A retrospective multicenter study","volume":"37","author":"Necchi","year":"2019","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib97","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.clgc.2016.03.005","article-title":"Prognostic Factors of Adjuvant Taxane, Cisplatin, and 5-Fluorouracil Chemotherapy for Patients With Penile Squamous Cell Carcinoma After Regional Lymphadenectomy","volume":"14","author":"Necchi","year":"2016","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105608_bib98","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/bju.14013","article-title":"First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study","volume":"121","author":"Necchi","year":"2018","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2026.105608_bib99","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1200\/JCO.2011.34.8367","article-title":"Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis","volume":"29","author":"Necchi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib100","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.clgc.2017.02.002","article-title":"Clinical Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced Penile Squamous-Cell Carcinoma: Results of a Multicenter Analysis","volume":"15","author":"Necchi","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105608_bib101","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/bjc.2013.620","article-title":"Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001)","volume":"109","author":"Nicholson","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105608_bib102","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41416-021-01574-9","article-title":"VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis","volume":"126","author":"Nicholson","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105608_bib103","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clgc.2015.07.009","article-title":"A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings","volume":"14","author":"Nicolai","year":"2016","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105608_bib104","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/bju.16384","article-title":"Fluorescence-guided surgery using cetuximab-800CW in patients with penile carcinoma","volume":"134","author":"Nijboer","year":"2024","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2026.105608_bib105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0974-7796.102659","article-title":"Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer","volume":"4","author":"Noronha","year":"2012","journal-title":"Urol. Ann."},{"key":"10.1016\/j.critrevonc.2026.105608_bib106","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.juro.2016.12.089","article-title":"A Prospective Study of Total Glans Resurfacing for Localized Penile Cancer to Maximize Oncologic and Functional Outcomes in a Tertiary Referral Network","volume":"197","author":"O\u2019Kelly","year":"2017","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib107","author":"Oryx GmbH","year":"2017","journal-title":"Pilot Study Concurrent Cisplatin-based Chemotherapy Combined Vaccination Therapy P16_37-63 Peptide Patients HPV- p16INK4a-positive Cancer (Clinical trial registration No. NCT02526316)"},{"key":"10.1016\/j.critrevonc.2026.105608_bib108","doi-asserted-by":"crossref","DOI":"10.1200\/OA-25-00110","article-title":"Outcomes of Patients With Rare Cancers Treated With Combination Immune Checkpoint Inhibitors With and Without Previous Anti\u2013PD-1\/L1 Exposure: National Cancer Institute\/SWOG S1609","author":"Othus","year":"2025","journal-title":"JCO Oncol. Adv."},{"key":"10.1016\/j.critrevonc.2026.105608_bib109","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijrobp.2023.03.066","article-title":"A Prospective Study of Chemoradiotherapy as Primary Treatment in Patients With Locoregionally Advanced Penile Carcinoma","volume":"117","author":"Ottenhof","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105608_bib110","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.juro.2016.09.088","article-title":"Expression of Programmed Death Ligand 1 in Penile Cancer is of Prognostic Value and Associated with HPV Status","volume":"197","author":"Ottenhof","year":"2017","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib111","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3389\/fimmu.2018.01253","article-title":"The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma","volume":"9","author":"Ottenhof","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib112","doi-asserted-by":"crossref","first-page":"S680","DOI":"10.1016\/j.annonc.2024.08.1058","article-title":"999MO HARE-40: A phase I\/II trial of therapeutic HPV vaccine (BNT113) in patients with HPV16 driven carcinoma","volume":"35","author":"Ottensmeier","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib113","doi-asserted-by":"crossref","first-page":"TPS5108","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS5108","article-title":"A phase II trial of enfortumab vedotin for locally advanced and metastatic squamous cell carcinoma of the penis","volume":"42","author":"Pagliaro","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib114","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3390\/cancers16112086","article-title":"Therapeutic Targets in Advanced Penile Cancer: From Bench to Bedside","volume":"16","author":"Pagliaro","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105608_bib115","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib116","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib117","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.euf.2021.11.008","article-title":"Glansectomy and Reconstruction for Penile Cancer: A Systematic Review","volume":"8","author":"Pang","year":"2022","journal-title":"Eur. Urol. Focus."},{"key":"10.1016\/j.critrevonc.2026.105608_bib118","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2026.03.022","article-title":"European Association of Urology and American Society of Clinical Oncology Guidelines on Penile Cancer: A Summary of the 2026 Guidelines Update","volume":"90","author":"Parnham","year":"2026","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib119","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clon.2019.06.013","article-title":"A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy","volume":"31","author":"Parwaiz","year":"2019","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib120","first-page":"389","article-title":"Updates in the use of radiotherapy in the management of primary and locally-advanced penile cancer","volume":"9","author":"Patel","year":"2022","journal-title":"Asian J. Urol. Adv. Field rare Genitourin. Tumor. Chall. Oppor."},{"key":"10.1016\/j.critrevonc.2026.105608_bib121","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.41.1700737","article-title":"The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?","volume":"23","author":"Patel","year":"2018","journal-title":"Eur. Surveill."},{"key":"10.1016\/j.critrevonc.2026.105608_bib122","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/0974-7796.127011","article-title":"Palliative chemotherapy in carcinoma penis: Does platinum and taxane combination holds a promise?","volume":"6","author":"Patil","year":"2014","journal-title":"Urol. Ann."},{"key":"10.1016\/j.critrevonc.2026.105608_bib123","doi-asserted-by":"crossref","first-page":"200.e11","DOI":"10.1016\/j.urolonc.2022.02.014","article-title":"Effectiveness and safety of adjuvant chemotherapy compared to neoadjuvant chemotherapy in patients with penile cancer and positive lymph nodes regarding overall survival and free disease survival: a systematic review and meta-analysis","volume":"40","author":"Paz Rojas","year":"2022","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib124","doi-asserted-by":"crossref","first-page":"TPS7","DOI":"10.1200\/JCO.2022.40.6_suppl.TPS7","article-title":"The international penile advanced cancer trial (InPACT): The first phase III trial for squamous carcinoma of the penis with regional lymph node metastases","volume":"40","author":"Pettaway","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib125","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.juro.2012.05.012","article-title":"Conservative Surgery for Squamous Cell Carcinoma of the Penis: Resection Margins and Long-Term Oncological Control","volume":"188","author":"Philippou","year":"2012","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib126","doi-asserted-by":"crossref","first-page":"S720","DOI":"10.1016\/j.annonc.2021.08.111","article-title":"715P Nivolumab in pretreated metastatic penile squamous cell carcinoma: Results of the penile cohort from the French AcS\u00e9 prospective program","volume":"32","author":"Pouessel","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.682030","article-title":"Distinct Patterns of Myeloid Cell Infiltration in Patients With hrHPV-Positive and hrHPV-Negative Penile Squamous Cell Carcinoma: The Importance of Assessing Myeloid Cell Densities Within the Spatial Context of the Tumor","volume":"12","author":"Rafael","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib128","author":"Ramos","year":"2025","journal-title":"HPV-16\/18 E6\/E7-Specif. T Lymph. Patients Relapsed HPV-Assoc. Cancers (Clin. Trial Regist. No. NCT02379520)"},{"key":"10.1016\/j.critrevonc.2026.105608_bib129","unstructured":"Rao, Xuemin, 2024. A Multicenter, Single Arm, Open Label, Phase I Clinical Study to Evaluate the Safety, Tolerability and Efficacy of HRYZ-T101 Injection for HPV18 Positive Solid Tumor (Clinical trial registration No. NCT05952947). clinicaltrials.gov."},{"key":"10.1016\/j.critrevonc.2026.105608_bib130","doi-asserted-by":"crossref","DOI":"10.1097\/01.JU.0000556432.48421.1e","article-title":"MP49-09 adjuvant chemotherapy in the treatment of lymph node positive squamous cell carcinoma of the penis: analysis of the national cancer data base","author":"Raup","year":"2019","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib131","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eururo.2018.04.003","article-title":"Risks and Benefits of Adjuvant Radiotherapy After Inguinal Lymphadenectomy in Node-positive Penile Cancer: A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel","volume":"74","author":"Robinson","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib132","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/RLU.0b013e318238f6ea","article-title":"Accuracy of 18F-FDG PET\/CT for Diagnosing Inguinal Lymph Node Involvement in Penile Squamous Cell Carcinoma: Systematic Review and Meta-Analysis of the Literature","volume":"37","author":"Sadeghi","year":"2012","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2026.105608_bib133","first-page":"8","article-title":"Epidemiology of penile cancer from the 20th to the 21st century: a literature review","author":"Santana","year":"2023","journal-title":"AME Med. J."},{"key":"10.1016\/j.critrevonc.2026.105608_bib134","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0022-5347(17)37327-5","article-title":"Cisplatin and 5-fluorouracil in advanced cancer of the penis","volume":"147","author":"Shammas","year":"1992","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib135","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41416-025-03321-w","article-title":"Efficacy and safety of tislelizumab combined with chemotherapy for locally advanced penile cancer: a prospective, single-arm clinical study","volume":"134","author":"Shan","year":"2026","journal-title":"Br. J. Cancer"},{"issue":"e17\u201323","key":"10.1016\/j.critrevonc.2026.105608_bib136","first-page":"496","article-title":"Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study","volume":"33","author":"Sharma","year":"2015","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib137","article-title":"Anti-epidermal growth factor receptor monoclonal antibody combined with chemotherapy in penile cancer: A prospective, multicenter, phase 1 study","author":"Shu","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105608_bib138","doi-asserted-by":"crossref","first-page":"S1696","DOI":"10.1016\/j.annonc.2025.09.048","article-title":"LBA37 A phase II study of avelumab in locally advanced or metastatic penile cancer patients unfit for platinum-based chemotherapy or progressed on or after platinum-based chemotherapy (ALPACA)","volume":"36","author":"Sridhar","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib139","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40487-020-00135-z","article-title":"Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature","volume":"9","author":"Stecca","year":"2021","journal-title":"Oncol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105608_bib140","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001395","article-title":"Bintrafusp alfa, a bifunctional fusion protein targeting TGF-\u03b2 and PD-L1, in patients with human papillomavirus-associated malignancies","volume":"8","author":"Strauss","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105608_bib141","doi-asserted-by":"crossref","first-page":"605.e17","DOI":"10.1016\/j.urolonc.2017.06.001","article-title":"Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: A multi-institutional study","volume":"35","author":"Tang","year":"2017","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib142","first-page":"147","article-title":"Laser ablation as monotherapy for penile squamous cell carcinoma: A multi-center cohort analysis","volume":"36","author":"Tang","year":"2018","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"10.1016\/j.critrevonc.2026.105608_bib143","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40814-024-01474-8","article-title":"A study protocol for a feasibility randomised controlled trial investigating videoendoscopic radical inguinal lymphadenectomy versus open radical inguinal lymphadenectomy in patients with penile cancer (VELRAD)","volume":"10","author":"Tang","year":"2024","journal-title":"Pilot. Feasibility Stud."},{"key":"10.1016\/j.critrevonc.2026.105608_bib144","unstructured":"The Netherlands Cancer Institute, 2025. A Phase 2 Clinical Study to Assess Efficacy of Induction Carboplatin\/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer: PRIAM (Clinical trial registration No. NCT06353906). clinicaltrials.gov.."},{"key":"10.1016\/j.critrevonc.2026.105608_bib145","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/annonc\/mdn149","article-title":"A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)","volume":"19","author":"Theodore","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib146","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.2023.41.6_suppl.8","article-title":"Activity and tolerability of maintenance avelumab (AVE) immunotherapy after first-line platinum-based polychemotherapy in patients (pts) with locally advanced or metastatic squamous cell penile carcinoma: Initial results of PULSE study","volume":"41","author":"Thiery-Vuillemin","year":"2023","journal-title":"JCO"},{"key":"10.1016\/j.critrevonc.2026.105608_bib147","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-021-00246-5","article-title":"Penile cancer","volume":"7","author":"Thomas","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.critrevonc.2026.105608_bib148","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s13277-014-2864-2","article-title":"Pathologic and imunohistochemical characterization of tumoral inflammatory cell infiltrate in invasive penile squamous cell carcinomas: Fox-P3 expression is an independent predictor of recurrence","volume":"36","author":"Vassallo","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib149","doi-asserted-by":"crossref","first-page":"TPS2690","DOI":"10.1200\/JCO.2025.43.16_suppl.TPS2690","article-title":"Phase II basket study to evaluate the tissue-agnostic efficacy of anti-PD1 in patients with advanced rare tumors: The ANTARES trial","volume":"43","author":"Venchiarutti Moniz","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib150","unstructured":"Wang, H., 2024. Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors (Clinical trial registration No. NCT06684327). clinicaltrials.gov."},{"key":"10.1016\/j.critrevonc.2026.105608_bib151","unstructured":"Wang, H., 2025. Ivonescimab (PD-1\/VEGF Bispecpecial Antibody) in the Treatment of Multiple Advanced Tumors: a Multi-cohort, Multi-center, Single-arm Phase II Study (Clinical trial registration No. NCT06683846). clinicaltrials.gov."},{"key":"10.1016\/j.critrevonc.2026.105608_bib152","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.urology.2014.12.049","article-title":"Treatment for Metastatic Penile Cancer After First-line Chemotherapy Failure: Analysis of Response and Survival Outcomes","volume":"85","author":"Wang","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2026.105608_bib153","doi-asserted-by":"crossref","first-page":"92.e11","DOI":"10.1016\/j.urolonc.2017.11.005","article-title":"Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database","volume":"36","author":"Winters","year":"2018","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib154","unstructured":"Xencor, Inc, 2023. A Phase 1 Multiple-Dose Study to Evaluate the Safety and Tolerability of XmAb\u00ae22841 Monotherapy and in Combination With Pembrolizumab in Subjects With Selected Advanced Solid Tumors (DUET-4) (Clinical trial registration No. NCT03849469). clinicaltrials.gov.."},{"key":"10.1016\/j.critrevonc.2026.105608_bib155","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/bju.16231","article-title":"Efficacy of indocyanine green fluorescence-guided inguinal lymph node dissection for penile cancer: a randomised trial","volume":"133","author":"Yuan","year":"2024","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2026.105608_bib156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euros.2022.08.020","article-title":"Light green up\u201d: Indocyanine Green Fluorescence Imaging\u2013guided Robotic Bilateral Inguinal Lymphadenectomy by the Hypogastric Subcutaneous Approach for Penile Cancer","volume":"45","author":"Yuan","year":"2022","journal-title":"Eur. Urol. Open. Sci."},{"key":"10.1016\/j.critrevonc.2026.105608_bib157","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00345-018-2280-0","article-title":"The relationship between HPV status and chemoradiotherapy in the locoregional control of penile cancer","volume":"36","author":"Yuan","year":"2018","journal-title":"World J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105608_bib158","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.2025.43.5_suppl.8","article-title":"Apatinib monotherapy for pretreated advanced squamous cell carcinoma of the penis: A phase II trial","volume":"43","author":"Zhang","year":"2025","journal-title":"J. Clin. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T07:06:57Z","timestamp":1791788817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826004956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":158,"alternative-id":["S1040842826004956"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105608","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current management and investigational therapeutic strategies in penile squamous cell carcinoma: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105608"}}